Page 25 - Usfda

Zydus launches cheapest remdesivir at Rs 2,800 per 100 mg vial in India

Potential Covid-19 treatment drug launched under brand name Remdac in India

Lupin, Sun Pharma recalling products in the US market, says USFDA

Leading drug makers Lupin and Sun Pharma are recalling different products in the US, according to the US Food and Drug Administration (USFDA).

Lupin alliance partner Concord gets USFDA nod for generic medicine

Concord has received approval from the US Food and Drug Administration (USFDA) to market the drug to prevent organ transplant rejection

Unichem gets USFDA nod for generic version of tolterodine tartrate tablets

The tolterodine tartrate tablets are generic versions of Pfizer Inc's DETROL tablets

Roche gets USFDA okay for transplant patients Epstein-Barr virus test

Roche has received authorisation from the United States' Food and Drug Administration (FDA) for its cobas 6800/8800 diagnostic tests for transplant patients

Lupin gets US FDA approval to market generic diabetes drug in the US

The Mumbai-based company has received a tentative approval from the USFDA for its Empagliflozin tablets

Zydus Cadila gets tentative USFDA nod to market Parkinson's disease drug

The drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad

Trailing in the value chain: Domestic pharma's unfinished agenda

In the first of a 5-part series, we look at reasons keeping Indian pharma sector from becoming the best globally

Lupin, Granules India recall 971,000 diabetes drug bottles from US market

As per the USFDA, the companies are recalling the product due to deviation from the current good manufacturing practices

Covid-19: Favipiravir triggers a price war; new brand launched at Rs 39

According to industry insiders, many more brands are lined up for launch, including one from Cipla

Bengaluru tech firm to produce NASA-designed, US FDA-approved ventilators

The firm said it is among a handful of Indian companies licenced by NASA for meeting the worldwide acute shortage of ventilators needed in treating Covid-19 patients

Zydus gets USFDA nod for drug trials to treat chemotherapy-induced anemia

Drug firm Zydus Cadila on Thursday said it has received approval from the US health regulator to initiate clinical trials for its drug 'Desidustat' in treatment of chemotherapy-induced anemia

Covid-19 treatment: A lowdown on possible cure and drugs being used

Business Standard takes a look at the common drugs that are being used in India for treating Covid-19 patients

Zydus Cadila gets USFDA nod to market generic drug to treat headache

The drug will be manufactured at Nesher Pharma's manufacturing facility at St. Louis in the US, the drug firm says

Biogen seeks US approval for potential Alzheimer's drug, stock jumps

The number of people in the United States living with Alzheimer's, the most common form of dementia, is expected to triple to nearly 14 million by 2050 without effective treatments

Debate on drug to treat Covid-19 politicised; India uses it: White House

The idea that hydroxychloroquine is a dangerous drug is 'just silly', says Peter Navarro, White House Office of Trade and Manufacturing Policy Director.

FDA chief declines to back Donald Trump's 'harmless' coronavirus claim

US Food and Drug Administration Commissioner Hahn said the coronavirus pandemic is "a rapidly evolving situation" but stressed that the US "absolutely must take this seriously"

Policy flip-flops may puncture India's image as 'pharmacy of the world'

India supplies almost 20 per cent of the medicines consumed by the world. Every third tablet in the US market is from India

Sequoia-backed Qure.ai gets USFDA nod for CT scan, first for Indian AI firm

American regulator's decision covers four critical abnormalities identified by Qure.ai's emergency room product namely intracranial bleeds, mass effect, midline shift, and cranial fractures

USFDA to release guidance on Covid-19 vaccine approval: Report

Experts have suggested that it could take a minimum of 12 to 18 months to guarantee a safe and effective vaccine through clinical trials